Tfo Tdc, LLC Exelixis, Inc. Transaction History

Tfo Tdc, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $281,129 - $333,536	-13,938 Reduced 99.99%	1 $0
Q4 2023 Feb 12, 2024	BUY	$19.25 - $24.13 $267,960 - $335,889	13,920 Added 73263.16%	13,939 $334,000
Q3 2023 Nov 02, 2023	BUY	$19.04 - $22.74 $342 - $409	18 Added 1800.0%	19 $0
Q1 2023 May 03, 2023	SELL	$16.3 - $19.41 $32 - $38	-2 Reduced 66.67%	1 $0
Q4 2022 Feb 03, 2023	BUY	$14.96 - $17.39 $44 - $52	3 New	3 $0

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.